Phase 2 Anaemia Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery
Cardiac SurgeryChronic Iron Deficiency Anaemia
University Health Network, Toronto60 enrolled3 locationsNCT06287619
Recruiting
Phase 2
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Elderly (People Aged 65 or More)Sever Aplastic AnaemiaImmunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China65 enrolled1 locationNCT07010237
Recruiting
Phase 2
Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A
Aplastic Anaemia
Peking Union Medical College Hospital40 enrolled1 locationNCT06802055
Recruiting
Phase 2
IV iron infusion therapy in patients with persistent pain
Iron deficiency anaemia
Metro North Health Services Royal Brisbane and Women's Hospital160 enrolled1 locationACTRN12622000412730
Recruiting
Phase 2Phase 3
ITHRIVE: Iron and erythropoietin use in anaemic patients in the intensive care
Critical IllnessAnaemia
Fiona Stanley Hospital550 enrolled9 locationsACTRN12621000595819
Recruiting
Phase 2
REscuing bone marrow function in patients with aplaStic anaEmia and bone marrow faiLure post allogEneiC Transplantation (RESELECT) Phase I/II single arm with historical control study assessing the efficacy and safety of Atorvastatin and N-Acetyl Cysteine in the treatment of Poor Graft Function post allogeneic transplantation and relapsed/refractory aplastic anaemia
One of the health conditions being studied in this trial will be Poor Graft FunctionOne of the health conditions being studied in this trial will be Aplastic Anaemia
The Royal Melbourne Hospital20 enrolled1 locationACTRN12620001339943
Active
Phase 2
Avatrombopag in Relapsed or Refractory Severe Aplastic Anaemia – a Bayesian Optimal Phase II study
Refractory/relapsed severe aplastic anaemia
Monash University55 enrolled12 locationsACTRN12619001043123
Active
Phase 2
Avatrombopag in untreated severe aplastic anaemia - a Bayesian optimal phase 2 study
Newly diagnosed severe aplastic anaemia
Monash University55 enrolled12 locationsACTRN12619001042134
Not Yet Recruiting
Phase 2Phase 3
The IRONWOMAN pilot feasibility study: oral versus intravenous iron therapy for iron deficiency anaemia in late pregnancy
Iron Deficiency Anaemia of Pregnancy
Dr Amanda Henry50 enrolled2 locationsACTRN12619000283178
Completed
Phase 2Phase 3
Should we treat iron deficiency anaemia of pregnancy with lactoferrin? A randomised controlled trial Lactoferrin Evaluation in Anaemia in Pregnancy: LEAP-1
Iron Deficient Anaemia in Pregnancy
University of Sydney900 enrolled1 locationACTRN12614000988651
Recruiting
Phase 2
Dose finding study for Polysialylated Erythropoietin (PSA-EPO) in Chronic Kidney Disease (CKD) subjects
Anaemia in Chronic Kidney Disease
Xenetic Biosciences PLC90 enrolled1 locationACTRN12613000504718
Active
Phase 2
Intravenous iRon or placebO for aNaeMiA in iNtensive care: The Ironman Randomised Controlled Trial
Anaemia in critical illness
Edward Litton140 enrolled4 locationsACTRN12612001249842
Not Yet Recruiting
Phase 2
Safety of RAPid INJECTion of Undiluted Ferric Carboxymaltose to Patients with Iron Deficiency Anaemia (RAPINJECT)
Iron deficiency anaemia
Haematology Unit, Monash Medical Centre, Southern Health154 enrolled1 locationACTRN12612000653864